Pulmonx FY 2021: revenue $48.4M, up 48%; diluted EPS −$1.35

Key figures from this report

These are the numbers Pulmonx reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$48.4M+48% from $32.7M in FY 202010-K income statement, on EDGAR
2. Net income−$48.7MAgainst −$32.2M in FY 202010-K income statement, on EDGAR
3. Diluted EPS−$1.35Against −$3.16 in FY 202010-K income statement, on EDGAR
4. Cash and cash equivalents$148.5M−36% from $231.6M in FY 2020Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations−$41.4MAgainst −$30.6M in FY 202010-K cash flow statement, on EDGAR

Every year in the financial tables